Given that the immune function of patients with TB is generally impaired, and CD4 and CD8 T cells have an important role in controlling TB infection (42, 43), an evaluation of the functional phenotypes of circulating immune cells is needed in the context of Vγ9Vδ2 T-cell therapy. The gene discussed is CD8A; the disease is tuberculosis.